The prescribing information for Leqembi approved by the FDA includes a warning for amyloid-related imaging abnormalities (ARIA), which are known to occur with antibodies of this class, and the two ...
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi ... imaging abnormalities (ARIA), involving swelling and potential ...
After hours: March 21 at 6:06:33 PM EDT Loading Chart for E ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback